12.87
-0.09 (-0.69%)
| Previous Close | 12.96 |
| Open | 13.20 |
| Volume | 8,789,299 |
| Avg. Volume (3M) | 10,127,219 |
| Market Cap | 8,770,003,968 |
| Price / Earnings (TTM) | 12.38 |
| Price / Earnings (Forward) | 12.50 |
| Price / Sales | 1.31 |
| Price / Book | 1.44 |
| 52 Weeks Range | |
| Earnings Date | 24 Jul 2025 - 28 Jul 2025 |
| Profit Margin | 10.70% |
| Operating Margin (TTM) | 8.21% |
| Diluted EPS (TTM) | 1.04 |
| Quarterly Revenue Growth (YOY) | -5.90% |
| Quarterly Earnings Growth (YOY) | 6.80% |
| Total Debt/Equity (MRQ) | 67.34% |
| Current Ratio (MRQ) | 1.12 |
| Operating Cash Flow (TTM) | 808.50 M |
| Levered Free Cash Flow (TTM) | 751.08 M |
| Return on Assets (TTM) | 3.53% |
| Return on Equity (TTM) | 12.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bearish | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Mixed | |
| Stock | Avantor, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | 2.5 |
| Price Volatility | 3.0 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | -0.5 |
| Average | 0.90 |
|
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Core |
| % Held by Insiders | 1.22% |
| % Held by Institutions | 103.36% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| New Mountain Capital, L.L.C. | 31 Dec 2024 | 14,000,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 24.00 (Raymond James, 86.48%) | Buy |
| Median | 17.00 (32.09%) | |
| Low | 14.00 (Goldman Sachs, 8.78%) | Hold |
| 14.00 (Stifel, 8.78%) | Hold | |
| Average | 17.67 (37.30%) | |
| Total | 5 Buy, 4 Hold | |
| Avg. Price @ Call | 13.86 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Goldman Sachs | 29 Apr 2025 | 14.00 (8.78%) | Hold | 12.69 |
| Baird | 28 Apr 2025 | 17.00 (32.09%) | Buy | 12.49 |
| Barclays | 28 Apr 2025 | 15.00 (16.55%) | Buy | 12.49 |
| 10 Apr 2025 | 18.00 (39.86%) | Buy | 14.70 | |
| Morgan Stanley | 28 Apr 2025 | 15.00 (16.55%) | Hold | 12.49 |
| 10 Feb 2025 | 25.00 (94.25%) | Buy | 19.01 | |
| RBC Capital | 28 Apr 2025 | 20.00 (55.40%) | Buy | 12.49 |
| 10 Feb 2025 | 31.00 (140.87%) | Buy | 19.01 | |
| Stifel | 28 Apr 2025 | 14.00 (8.78%) | Hold | 12.49 |
| 10 Feb 2025 | 26.00 (102.02%) | Buy | 19.01 | |
| Wells Fargo | 17 Apr 2025 | 22.00 (70.94%) | Buy | 15.10 |
| 10 Feb 2025 | 25.00 (94.25%) | Buy | 19.01 | |
| Citigroup | 04 Mar 2025 | 18.00 (39.86%) | Hold | 15.50 |
| Raymond James | 10 Feb 2025 | 24.00 (86.48%) | Buy | 19.01 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| KANG LAN | 12.49 | - | 5,000 | 62,450 |
| MASSARO JOSEPH R | 12.69 | - | 8,100 | 102,789 |
| PEACOCK JONATHAN M | 12.49 | - | 8,091 | 101,057 |
| SUMME GREGORY L | 12.49 | - | 25,000 | 312,250 |
| Aggregate Net Quantity | 46,191 | |||
| Aggregate Net Value ($) | 578,546 | |||
| Aggregate Avg. Buy ($) | 12.54 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MASSARO JOSEPH R | Director | 29 Apr 2025 | Buy (+) | 8,100 | 12.69 | 102,789 |
| PEACOCK JONATHAN M | Director | 28 Apr 2025 | Buy (+) | 8,091 | 12.49 | 101,057 |
| KANG LAN | Director | 28 Apr 2025 | Buy (+) | 5,000 | 12.49 | 62,450 |
| SUMME GREGORY L | Director | 28 Apr 2025 | Buy (+) | 25,000 | 12.49 | 312,250 |
| Date | Type | Details |
|---|---|---|
| 02 May 2025 | Announcement | Avantor® to Participate in Bank of America Securities 2025 Health Care Conference |
| 25 Apr 2025 | Announcement | Avantor® Announces CEO Transition |
| 25 Apr 2025 | Announcement | Avantor® Reports First Quarter 2025 Results |
| 01 Apr 2025 | Announcement | Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX |
| 28 Mar 2025 | Announcement | Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025 |
| 17 Mar 2025 | Announcement | Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025 |
| 19 Feb 2025 | Announcement | Avantor® to Present at TD Cowen's 45th Annual Health Care Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |